Duodenal Ulcers

• FDA approval · 2024-12-10
  FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)

  FDA approved a supplemental application for esomeprazole magnesium from Ascend Laboratories, LLC, under an approved ANDA.

• FDA approval · 2024-03-05
  FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)

  FDA approved a supplemental application for pantoprazole sodium submitted by Eugia US LLC.

• FDA approval · 2024-02-01
  FDA Approved: METHSCOPOLAMINE BROMIDE — Original Application (i3 Pharmaceuticals, LLC)

  FDA approved the original application for methscopolamine bromide, a generic anticholinergic agent, filed by i3 Pharmaceuticals, LLC.

• FDA approval · 2023-12-20
  FDA Approved: FAMOTIDINE — Original Application (Westminster Pharmaceuticals, LLC)

  FDA approves Westminster Pharmaceuticals' original ANDA for famotidine, a generic H2 blocker used to treat ulcers and GERD.

• FDA approval · 2023-10-18
  FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Granules Pharmaceuticals Inc.)

  FDA approved Granules Pharmaceuticals' original application for esomeprazole magnesium, a proton pump inhibitor, as a generic drug. It is in…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2022-08-04
  FDA Approved: FAMOTIDINE — Original Application (Amneal Pharmaceuticals NY LLC)

  FDA approves Amneal's original application for famotidine, enabling a generic version of the H2 blocker. The approval covers common indicati…

• FDA approval · 2022-05-19
  FDA Approved: PANTOPRAZOLE SODIUM I.V. — Original Application (Piramal Critical Care)

  FDA approved Pantoprazole sodium for injection (IV) from Piramal Critical Care under an original application.

• FDA approval · 2022-02-18
  FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)

  The FDA approved a supplemental application for PEPCID AC MAXIMUM STRENGTH (famotidine) from Kenvue Brands LLC.

• FDA approval · 2018-06-07
  FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) submitted by Wyeth Pharmaceuticals LLC (Pfize…

• FDA approval · 2017-02-07
  FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC (ANDA 077824).

• CLINICAL_TRIALS trial_result · 2014-05-08
  Clinical Trial Update: Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) [Phase 3]

  Phase 3 long-term extension study evaluating TAK-438 (vonoprazan) for preventing recurrent gastric or duodenal ulcers in patients on NSAIDs;…

• CLINICAL_TRIALS trial_result · 2014-05-08
  Clinical Trial Update: Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin [Phase 3]

  TAK-438 (tegoprazan) was evaluated in a long-term extension Phase 3 trial to prevent recurrent gastric or duodenal ulcers in patients on low…

• FDA approval · 2012-01-20
  FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)

  The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.

• FDA approval · 2010-01-31
  FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)

  The FDA approved a supplemental application for ranitidine filed by Pharmaceutical Associates, Inc., updating the drug's labeling. This acti…

• FDA approval · 2009-08-31
  FDA Approved: RANITIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)

  FDA approved a supplemental application for ranitidine by Dr. Reddy's Laboratories Limited.

• FDA approval · 2008-03-20
  FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC, authorizing the continued marketing of a…